| 1 |
32034167 | Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection. | 2020 Feb 7 |
1 |
| 2 |
32486887 | Peripheral Expression of CXCL10 Gene in Chronic Hepatitis C Patients Treated with Sofosbuvir, Daclatasvir, and Ribavirin. | 2020 Jun |
5 |
| 3 |
33612760 | Interferon-γ inducible protein-10 and interleukin 28B gene polymorphism as predictive markers for genotype 4 hepatitis C virus treatment response. | 2020 Dec 1 |
2 |
| 4 |
30201505 | First description of agonist and antagonist IP-10 in urine of patients with active TB. | 2019 Jan |
1 |
| 5 |
31485460 | Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C? | 2019 |
1 |
| 6 |
30507970 | Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patients. | 2018 |
1 |
| 7 |
26521772 | Editorial: New Therapies, Markers and Therapeutic Targets in HCV Chronic Infection and HCV Extrahepatic Manifestations. | 2017 |
1 |
| 8 |
29528582 | Interleukin-22 and Chemokine Interferon γ -Inducible-10 (IP-10) Levels in Chronic Hepatitis C Patients and Treatment Response to Pegylated Interferon and Ribavirin Therapy. | 2017 Jun |
1 |
| 9 |
26344576 | High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity. | 2016 Mar |
2 |
| 10 |
26470765 | Association of IL28B Genotypes and Baseline Serum Interferon-γ-Inducible- Protein-10 Levels with Treatment Response in Hepatitis C Virus Patients in China. | 2016 May 23 |
1 |
| 11 |
27167219 | Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection. | 2016 |
1 |
| 12 |
25512630 | Intrahepatic and Peripheral CXCL10 Expression in Hepatitis C Virus-Infected Patients Treated With Telaprevir, Pegylated Interferon, and Ribavirin. | 2015 Jun 1 |
2 |
| 13 |
25973761 | IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy. | 2015 Aug |
1 |
| 14 |
23396509 | Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C. | 2014 Jan |
1 |
| 15 |
24372894 | Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C. | 2014 Nov |
3 |
| 16 |
25218243 | CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients. | 2014 Nov |
1 |
| 17 |
25255161 | Ribavirin enhances myeloid-derived suppressor cell differentiation through CXCL9/10 downregulation. | 2014 Dec |
1 |
| 18 |
25387553 | IP-10 in chronic hepatitis C patients treated with high-dose interferon. | 2014 Oct |
1 |
| 19 |
22799464 | Chemokine CXCL10 at week 4 of treatment predicts sustained virological response in patients with chronic hepatitis C. | 2012 Aug |
1 |
| 20 |
21340353 | Soluble inflammatory markers as predictors of virological response in patients with chronic hepatitis C virus infection treated with interferon-α plus ribavirin. | 2011 Feb |
1 |
| 21 |
21376259 | IFN-stimulated gene expression is a useful potential molecular marker of response to antiviral treatment with Peg-IFNα 2b and ribavirin in patients with hepatitis C virus genotype 1. | 2011 Jan |
1 |
| 22 |
21390311 | Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms. | 2011 Feb 24 |
1 |
| 23 |
20303352 | Ribavirin improves early responses to peginterferon through improved interferon signaling. | 2010 Jul |
1 |
| 24 |
17414926 | Interferon gamma-inducible protein 10: a predictive marker of successful treatment response in hepatitis C virus/HIV-coinfected patients. | 2007 Jul 1 |
1 |
| 25 |
17560677 | The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection. | 2007 Nov |
1 |
| 26 |
16150856 | Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. | 2006 Mar |
2 |
| 27 |
16960776 | Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. | 2006 Oct 1 |
1 |
| 28 |
15860662 | Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. | 2005 Aug 15 |
1 |
| 29 |
14987324 | Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy. | 2004 Mar 1 |
1 |